Cassava sciences to report third quarter 2024 results on november 7, 2024

Austin, texas, oct. 31, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, announced today that it will hold a conference call on thursday, november 7th at 8:30 a.m. eastern time.

sava Ratings Summary

sava Quant Ranking